Asphaug L, Akslen LA, Blix ES, Boge B, Borgen EF, Brekke MB, Falk RS, Geitvik GA, Gilje B, Gravdehaug B, Heie A, Janssen E, Kiserud CE, Kursetgjerde T, Langerød A, Lømo J, Mannsåker B, Mortensen E, Olsson P, Porojnicu AC, Raj SX, Roe OD, Russnes HEG, Skjerven HK, Songe-Møller S et al. (2025)
Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives
Clin Breast Cancer (in press)
DOI 10.1016/j.clbc.2025.04.011, PubMed 40348620

Medhus A, Schink KO, Longva AS, Engebraaten O, Berg K, Weyergang A (2025)
The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases
Ther Adv Med Oncol, 17, 17588359251332473
DOI 10.1177/17588359251332473, PubMed 40297622

Sæter M, Johansen SH, Reinertsen KV, Thorsen L, Haugaa KH, Nilsen TS, Sarvari SI (2025)
Cardiorespiratory fitness, cardiac morphology and function, and cardiovascular risk factors in long-term breast cancer survivors compared with non-cancer controls
Cardiooncology, 11 (1), 1
DOI 10.1186/s40959-024-00296-0, PubMed 39755716